MTOR and neoplasm: We investigated the mechanisms of the metformin-induced tumor suppressive effect in the field of tumor microenvironment, and demonstrated that the metformin-induced activation of AMPK and subsequent mTOR inhibition decreased the MDSC and M2 macrophage populations by downregulating the mevalonate pathway.